LUCD:NASDAQ, Lucid Diagnostics Inc.

Why LUCD stock fell on November 16

Lucid Diagnostics Inc. fell 11.4% on Monday, November 16, 2026, on 2,169,800 shares. No headline about LUCD came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

LUCD stock overview

Lucid Diagnostics Inc. (LUCD:NASDAQ) closed at $0.373 on November 20, 2026, down 3.52% on the day. The stock trades 77.1% below its 52-week high of $1.63 and 23.0% above its 52-week low of $0.303. Over the past year, it lost 64.8%. Lucid Diagnostics Inc. is part of the Health Care sector.

Key figures

Price
$0.373
Day change
-3.52%
Volume
2,261,848
Average volume
5,123,193
Market cap
72M+
52-week range
$0.303 – $1.63
50-day average
$0.563
200-day average
$0.969

Price action over the past year

In 252 trading sessions since November 20, 2025, LUCD closed higher on 107 days (42%). Its best day was October 23, 2026 (+25.30%) and its worst was October 19, 2026 (-21.13%). The stock moved 10% or more in a single session 15 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

LUCD news

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.

Similar stocks

Find more stocks like LUCD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.